About this Journal Submit a Manuscript Table of Contents
Scientifica
Volume 2014 (2014), Article ID 746574, 10 pages
http://dx.doi.org/10.1155/2014/746574
Review Article

Perfluorocarbon Nanoparticles: Evolution of a Multimodality and Multifunctional Imaging Agent

Department of Radiology, Cincinnati Children’s Hospital, Cincinnati, OH 45229, USA

Received 25 December 2013; Accepted 20 May 2014; Published 12 June 2014

Academic Editor: Shamsul Hayat

Copyright © 2014 Patrick M. Winter. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. M. Lanza, S. D. Caruthers, P. M. Winter et al., “Angiogenesis imaging with vascular-constrained particles: the why and how,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, supplement 1, pp. S114–S126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. G. M. Lanza, P. M. Winter, S. D. Caruthers et al., “Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles,” Nanomedicine, vol. 1, no. 3, pp. 321–329, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. M. Lanza, P. M. Winter, S. D. Caruthers et al., “Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions,” Angiogenesis, vol. 13, no. 2, pp. 189–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. A. Wickline, A. M. Neubauer, P. M. Winter, S. D. Caruthers, and G. M. Lanza, “Molecular imaging and therapy of atherosclerosis with targeted nanoparticles,” Journal of Magnetic Resonance Imaging, vol. 25, no. 4, pp. 667–680, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. P. M. Winter, K. Cai, S. D. Caruthers, S. A. Wickline, and G. M. Lanza, “Emerging nanomedicine opportunities with perfluorocarbon nanoparticles,” Expert Review of Medical Devices, vol. 4, no. 2, pp. 137–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. P. M. Winter, S. D. Caruthers, G. M. Lanza, and S. A. Wickline, “Quantitative cardiovascular magnetic resonance for molecular imaging,” Journal of Cardiovascular Magnetic Resonance, vol. 12, no. 1, article 62, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. F. Flaim, “Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes,” Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 22, no. 4, pp. 1043–1054, 1994. View at Scopus
  8. R. F. Mattrey, “The potential role of perfluorochemicals (PFCS) in diagnostic imaging,” Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 22, no. 2, pp. 295–313, 1994. View at Scopus
  9. M. S. Hughes, J. N. Marsh, H. Zhang et al., “Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo,” IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 53, no. 9, pp. 1609–1616, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. S. Hughes, J. E. McCarthy, J. N. Marsh et al., “Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging,” Journal of the Acoustical Society of America, vol. 121, no. 6, pp. 3542–3557, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. N. Marsh, K. C. Partlow, D. R. Abendschein, M. J. Scott, G. M. Lanza, and S. A. Wickline, “Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes,” Ultrasound in Medicine and Biology, vol. 33, no. 6, pp. 950–958, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. N. Marsh, A. Senpan, G. Hu et al., “Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis,” Nanomedicine, vol. 2, no. 4, pp. 533–543, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. S. D. Caruthers, P. M. Winter, S. A. Wickline, and G. M. Lanza, “Targeted magnetic resonance imaging contrast agents,” Methods in Molecular Medicine, vol. 124, pp. 387–400, 2006. View at Scopus
  14. D. Pan, G. M. Lanza, S. A. Wickline, and S. D. Caruthers, “Nanomedicine: perspective and promises with ligand-directed molecular imaging,” European Journal of Radiology, vol. 70, no. 2, pp. 274–285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. D. Tran, S. D. Caruthers, M. Hughes et al., “Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics,” International Journal of Nanomedicine, vol. 2, no. 4, pp. 515–526, 2007.
  16. P. M. Winter, S. D. Caruthers, S. A. Wickline, and G. M. Lanza, “Molecular imaging by MRI,” Current Cardiology Reports, vol. 8, no. 1, pp. 65–69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. P. M. Winter, H. P. Shukla, S. D. Caruthers et al., “Molecular imaging of human thrombus with computed tomography,” Academic Radiology, vol. 12, supplement 1, pp. S9–S13, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Pan, S. D. Caruthers, J. Chen et al., “Nanomedicine strategies for molecular targets with MRI and optical imaging,” Future Medicinal Chemistry, vol. 2, no. 3, pp. 471–490, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Hu, M. Lijowski, H. Zhang et al., “Imaging of Vx-2 rabbit tumors with ανβ3-integrin-targeted 111In nanoparticles,” International Journal of Cancer, vol. 120, no. 9, pp. 1951–1957, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Lijowski, S. Caruthers, G. Hu et al., “High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model,” Investigative Radiology, vol. 44, no. 1, pp. 15–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. H. F. Zhou, H. W. Chan, S. A. Wickline, G. M. Lanza, and C. T. Pham, “αvβ3-Targeted nanotherapy suppresses inflammatory arthritis in mice,” FASEB Journal, vol. 23, no. 9, pp. 2978–2985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. F. Zhou, G. Hu, S. A. Wickline, G. M. Lanza, and C. T. Pham, “Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis,” Nanomedicine, vol. 5, no. 7, pp. 1065–1074, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Pan, O. Ivashyna, B. Sinha et al., “Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling,” Biomaterials, vol. 32, no. 1, pp. 231–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. G. M. Lanza, K. D. Wallace, M. J. Scott et al., “A novel site-targeted ultrasonic contrast agent with broad biomedical application,” Circulation, vol. 94, no. 12, pp. 3334–3340, 1996. View at Scopus
  25. S. A. Anderson, R. K. Rader, W. F. Westlin et al., “Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles,” Magnetic Resonance in Medicine, vol. 44, no. 33, pp. 433–439, 2000. View at Publisher · View at Google Scholar
  26. S. Flacke, S. Fischer, M. J. Scott et al., “Novel MRI contrast agent for molecular imaging of fibrin implications for detecting vulnerable plaques,” Circulation, vol. 104, no. 11, pp. 1280–1285, 2001. View at Scopus
  27. G. M. Lanza, K. D. Wallace, S. E. Fischer et al., “High-frequency ultrasonic detection of thrombi with a targeted contrast system,” Ultrasound in Medicine and Biology, vol. 23, no. 6, pp. 863–870, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. G. M. Lanza, X. Yu, P. M. Winter et al., “Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis,” Circulation, vol. 106, no. 22, pp. 2842–2847, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. Morawski, P. M. Winter, K. C. Crowder et al., “Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI,” Magnetic Resonance in Medicine, vol. 51, no. 3, pp. 480–486, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. K. S. Boles, A. H. Schmieder, A. W. Koch et al., “MR angiogenesis imaging with Robo4- versus αVβ3-targeted nanoparticles in a B16/F10 mouse melanoma model,” FASEB Journal, vol. 24, no. 11, pp. 4262–4270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. P. M. Winter, S. D. Caruthers, A. Kassner et al., “Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel ανβ3-targeted nanoparticle and 1.5 Tesla magnetic resonance imaging,” Cancer Research, vol. 63, no. 18, pp. 5838–5843, 2003. View at Scopus
  32. P. M. Winter, A. H. Schmieder, S. D. Caruthers et al., “Minute dosages of ανβ3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits,” FASEB Journal, vol. 22, no. 8, pp. 2758–2767, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. P. M. Winter, S. D. Caruthers, H. Zhang, T. A. Williams, S. A. Wickline, and G. M. Lanza, “Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis,” JACC: Cardiovascular Imaging, vol. 1, no. 5, pp. 624–634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. P. M. Winter, A. M. Morawski, S. D. Caruthers et al., “Molecular imaging of angiogenesis in early-stage atherosclerosis with αvβ3-integrin-targeted nanoparticles,” Circulation, vol. 108, no. 18, pp. 2270–2274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. P. M. Winter, A. M. Neubauer, S. D. Caruthers et al., “Endothelial ανβ3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 9, pp. 2103–2109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Cai, S. D. Caruthers, W. Huang et al., “MR molecular imaging of aortic angiogenesis,” JACC: Cardiovascular Imaging, vol. 3, no. 8, pp. 824–832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. P. M. Winter, S. D. Caruthers, J. S. Allen et al., “Molecular imaging of angiogenic therapy in peripheral vascular disease with ανβ3-integrin-targeted nanoparticles,” Magnetic Resonance in Medicine, vol. 64, no. 2, pp. 369–376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Cyrus, D. R. Abendschein, S. D. Caruthers et al., “MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles,” Journal of Cardiovascular Magnetic Resonance, vol. 8, no. 3, pp. 535–541, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. P. M. Winter, S. D. Caruthers, X. Yu et al., “Improved molecular imaging contrast agent for detection of human thrombus,” Magnetic Resonance in Medicine, vol. 50, no. 2, pp. 411–416, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Kassner, R. E. Thornhill, F. Liu et al., “Assessment of tumor angiogenesis: dynamic contrast-enhanced MRI with paramagnetic nanoparticles compared with Gd-DTPA in a rabbit Vx-2 tumor model,” Contrast Media and Molecular Imaging, vol. 5, no. 3, pp. 155–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. W. J. Akers, Z. Zhang, M. Berezin et al., “Targeting of αvνβ 3-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles,” Nanomedicine, vol. 5, no. 5, pp. 715–726, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Cyrus, P. M. Winter, S. D. Caruthers, S. A. Wickline, and G. M. Lanza, “Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy,” Expert Review of Cardiovascular Therapy, vol. 3, no. 4, pp. 705–715, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Winter, P. Athey, G. Kiefer et al., “Improved paramagnetic chelate for molecular imaging with MRI,” Journal of Magnetism and Magnetic Materials, vol. 293, no. 1, pp. 540–545, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. D. Caruthers, A. M. Neubauer, F. D. Hockett et al., “In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla,” Investigative Radiology, vol. 41, no. 3, pp. 305–312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. M. Morawski, P. M. Winter, X. Yu et al., “Quantitative “magnetic resonance immunohistochemistry” with ligand-targeted 19F nanoparticles,” Magnetic Resonance in Medicine, vol. 52, no. 6, pp. 1255–1262, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. A. M. Neubauer, J. Myerson, S. D. Caruthers et al., “Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging,” Magnetic Resonance in Medicine, vol. 60, no. 5, pp. 1066–1072, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. K. C. Partlow, J. Chen, J. A. Brant et al., “19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons,” FASEB Journal, vol. 21, no. 8, pp. 1647–1654, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. R. Southworth, M. Kaneda, J. Chen et al., “Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by 19F NMR of VCAM-1 targeted nanobeacons,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 5, no. 3, pp. 359–367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. E. A. Waters, J. Chen, J. S. Allen, H. Zhang, G. M. Lanza, and S. A. Wickline, “Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS,” Journal of Cardiovascular Magnetic Resonance, vol. 10, no. 1, article 43, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. E. A. Waters, J. Chen, X. Yang et al., “Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy,” Magnetic Resonance in Medicine, vol. 60, no. 5, pp. 1232–1236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Chen, G. M. Lanza, and S. A. Wickline, “Quantitative magnetic resonance fluorine imaging: today and tomorrow,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 2, no. 4, pp. 431–440, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Chen, H. Pan, G. M. Lanza, and S. A. Wickline, “Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy,” Advances in Chronic Kidney Disease, vol. 20, no. 6, pp. 466–478, 2013. View at Publisher · View at Google Scholar
  53. F. D. Hockett, K. D. Wallace, A. H. Schmieder et al., “Simultaneous dual frequency 1H and 19F open coil imaging of arthritic rabbit knee at 3 T,” IEEE Transactions on Medical Imaging, vol. 30, no. 1, pp. 22–27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. M. M. Kaneda, S. Caruthers, G. M. Lanza, and S. A. Wickline, “Perfluorocarbon Nanoemulsions for quantitative molecular imaging and targeted therapeutics,” Annals of Biomedical Engineering, vol. 37, no. 10, pp. 1922–1933, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. P. M. Winter, “Magnetic resonance chemical exchange saturation transfer imaging and nanotechnology,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 4, no. 4, pp. 389–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. P. M. Winter, K. Cai, J. Chen et al., “Targeted PARACEST nanoparticle contrast agent for the detection of fibrin,” Magnetic Resonance in Medicine, vol. 56, no. 6, pp. 1384–1388, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Cai, G. E. Kiefer, S. D. Caruthers, S. A. Wickline, G. M. Lanza, and P. M. Winter, “Quantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticles,” NMR in Biomedicine, vol. 25, no. 2, pp. 279–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. E. A. Perez and J. Spano, “Current and emerging targeted therapies for metastatic breast cancer,” Cancer, vol. 118, no. 12, pp. 3014–3025, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. D. A. Reardon, S. Turner, K. B. Peters et al., “A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma,” Journal of the National Comprehensive Cancer Network, vol. 9, no. 4, pp. 414–427, 2011. View at Scopus
  60. A. H. Schmieder, P. M. Winter, T. A. Williams et al., “Molecular MR imaging of neovascular progression in the vx2 tumor with αvβ3-targeted paramagnetic nanoparticles,” Radiology, vol. 268, no. 2, pp. 470–480, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. A. H. Schmieder, P. M. Winter, S. D. Caruthers et al., “Molecular MR imaging of melanoma angiogenesis with ανβ3-targeted paramagnetic nanoparticles,” Magnetic Resonance in Medicine, vol. 53, no. 3, pp. 621–627, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. E. R. O'Brien, M. R. Garvin, R. Dev et al., “Angiogenesis in human coronary atherosclerotic plaques,” The American Journal of Pathology, vol. 145, no. 4, pp. 883–894, 1994. View at Scopus
  63. M. Gössl, M. Rosol, N. M. Malyar et al., “Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries,” Anatomical Record A—Discoveries in Molecular, Cellular, and Evolutionary Biology, vol. 272, no. 2, pp. 526–537, 2003. View at Scopus
  64. R. Khurana, Z. Zhuang, S. Bhardwaj et al., “Angiogenesis-dependent and independent phases of intimal hyperplasia,” Circulation, vol. 110, no. 16, pp. 2436–2443, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. P. R. Moreno, K. R. Purushothaman, V. Fuster et al., “Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability,” Circulation, vol. 110, no. 14, pp. 2032–2038, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. A. N. Tenaglia, K. G. Peters, M. H. Sketch Jr., and B. H. Annex, “Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina,” The American Heart Journal, vol. 135, no. 1, pp. 10–14, 1998. View at Publisher · View at Google Scholar · View at Scopus
  67. A. M. Neubauer, H. Sim, P. M. Winter et al., “Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging,” Magnetic Resonance in Medicine, vol. 60, no. 6, pp. 1353–1361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. J. C. Russell, S. E. Graham, and P. J. Dolphin, “Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099),” Metabolism: Clinical and Experimental, vol. 48, no. 6, pp. 701–706, 1999. View at Publisher · View at Google Scholar · View at Scopus
  69. J. C. Russell, S. E. Graham, and M. Richardson, “Cardiovascular disease in the JCR:LA-cp rat,” Molecular and Cellular Biochemistry, vol. 188, no. 1-2, pp. 113–126, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. J. C. Russell, D. G. Koeslag, R. M. Amy, and P. J. Dolphin, “Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats,” Arteriosclerosis, vol. 9, no. 6, pp. 869–876, 1989. View at Scopus
  71. J. C. Russell, D. G. Koeslag, R. M. Amy, and P. J. Dolphin, “Independence of myocardial disease in the JCR:LA-corpulent rat on plasma cholesterol concentration,” Clinical and Investigative Medicine, vol. 14, no. 4, pp. 288–295, 1991. View at Scopus
  72. D. N. Brindley, P. Hales, A. I. I. Al-Sieni, and J. C. Russell, “Decreased serum lipids, serum insulin and triacylglycerol synthesis in adipose tissue of JCR:LA-corpulent rats treated with benfluorex,” Biochimica et Biophysica Acta—Lipids and Lipid Metabolism, vol. 1085, no. 1, pp. 119–125, 1991. View at Publisher · View at Google Scholar · View at Scopus
  73. J. C. Russell, S. E. Graham, P. J. Dolphin, R. M. Amy, G. O. Wood, and D. N. Brindley, “Antiatherogenic effects of long-term benfluorex treatment in male insulin resistant JCR:LA-cp rats,” Atherosclerosis, vol. 132, no. 2, pp. 187–197, 1997. View at Publisher · View at Google Scholar · View at Scopus
  74. J. C. Russell, S. E. Graham, P. J. Dolphin, and D. N. Brindley, “Effects of benfluorex on serum triacylglycerols and insulin sensitivity in the corpulent rat,” Canadian Journal of Physiology and Pharmacology, vol. 74, no. 8, pp. 879–886, 1996. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Duan, T. Murohara, H. Ikeda et al., “Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism,” Circulation, vol. 102, no. 19, supplement 3, pp. III370–III376, 2000. View at Scopus
  76. E. van Belle, A. Rivard, D. Chen et al., “Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines,” Circulation, vol. 96, no. 8, pp. 2667–2674, 1997. View at Scopus
  77. Y. Octavia, C. G. Tocchetti, K. L. Gabrielson, S. Janssens, H. J. Crijns, and A. L. Moens, “Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies,” Journal of Molecular and Cellular Cardiology, vol. 52, no. 6, pp. 1213–1225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Cyrus, H. Zhang, J. S. Allen et al., “Intramural delivery of rapamycin with αvβ3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 820–826, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Liu, J. Widom, C. W. Kemp, C. M. Crews, and J. Clardy, “Structure of human methionine aminopeptidase-2 complexed with fumagillin,” Science, vol. 282, no. 5392, pp. 1324–1327, 1998. View at Scopus
  80. N. Sin, L. Meng, M. Q. Wang, J. J. Wen, W. G. Bornmann, and C. M. Crews, “The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 12, pp. 6099–6103, 1997. View at Publisher · View at Google Scholar · View at Scopus
  81. E. C. Griffith, S. U. Zhuang, S. Niwayama, C. A. Ramsay, Y. Chang, and J. O. Liu, “Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 26, pp. 15183–15188, 1998. View at Publisher · View at Google Scholar · View at Scopus
  82. S. D. Caruthers, T. Cyrus, P. M. Winter, S. A. Wickline, and G. M. Lanza, “Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 1, no. 3, pp. 311–323, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. M. M. Kaneda, Y. Sasaki, G. M. Lanza, J. Milbrandt, and S. A. Wickline, “Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions,” Biomaterials, vol. 31, no. 11, pp. 3079–3086, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. N. R. Soman, S. L. Baldwin, G. Hu et al., “Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth,” Journal of Clinical Investigation, vol. 119, no. 9, pp. 2830–2842, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. N. R. Soman, G. M. Lanza, J. M. Heuser, P. H. Schlesinger, and S. A. Wickline, “Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides,” Nano Letters, vol. 8, no. 4, pp. 1131–1136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. L. Hu, J. Chen, X. Yang, S. D. Caruthers, G. M. Lanza, and S. A. Wickline, “Rapid quantification of oxygen tension in blood flow with a fluorine nanoparticle reporter and a novel blood flow-enhanced-saturation-recovery sequence,” Magnetic Resonance in Medicine, vol. 70, no. 1, pp. 176–183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. G. M. Lanza, J. N. Marsh, G. Hu et al., “Rationale for a nanomedicine approach to thrombolytic therapy,” Stroke, vol. 41, no. 10, supplement, pp. S42–S44, 2010. View at Publisher · View at Google Scholar · View at Scopus